MetLife Investment Management’s Athenex, Inc. Common Stock ATNX Stock Holding History

MetLife Investment Management’s Portfolio ATNX Stock Details ATNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-587	Closed	-$35.3K	–	2583
2021 Q3	$35.3K	Sell	587 -1,153	-66%	-$83.9K	﹤0.01%	2550
2021 Q2	$161K	Buy	1,740 +1,515	+673%	+$138K	﹤0.01%	2294
2021 Q1	$19.4K	Sell	225 -1,282	-85%	-$246K	﹤0.01%	2304
2020 Q4	$333K	Sell	1,507 -50	-3%	-$12.3K	﹤0.01%	1699
2020 Q3	$377K	Hold	1,557	–	–	﹤0.01%	1518
2020 Q2	$428K	Hold	1,557	–	–	﹤0.01%	1466
2020 Q1	$241K	Hold	1,557	–	–	﹤0.01%	1589
2019 Q4	$475K	Hold	1,557	–	–	0.01%	1490
2019 Q3	$379K	Buy	1,557 +185	+13%	+$60.5K	﹤0.01%	1566
2019 Q2	$543K	Buy	1,372 +363	+36%	+$101K	0.01%	1433
2019 Q1	$247K	Hold	1,009	–	–	﹤0.01%	1864
2018 Q4	$256K	Hold	1,009	–	–	﹤0.01%	1775
2018 Q3	$313K	Hold	1,009	–	–	﹤0.01%	1828
2018 Q2	$376K	Buy	+1,009	New	+$346K	﹤0.01%	1589

Other funds holding ATNX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MetLife Investment Management's ATNX Position: Q4 2021 in Review

MetLife Investment Management sold out of Athenex, Inc. Common Stock (ATNX) in Q4 2021, closing a stake of 587 shares — an estimated $35.3K sold.

MetLife Investment Management first reported a position in ATNX in Q2 2018 and held it in 14 quarters. The position peaked at $543K in Q2 2019. 103 funds tracked by Wall St. Rank hold ATNX as of Q4 2021.

MetLife Investment Management reported no remaining Athenex, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
MetLife Investment Management sold 587 Athenex, Inc. Common Stock shares in Q4 2021, an estimated $35.3K.
MetLife Investment Management first reported a position in Athenex, Inc. Common Stock in Q2 2018 and held it in 14 quarters.
MetLife Investment Management's Athenex, Inc. Common Stock position peaked at $543K in Q2 2019.
103 funds tracked by Wall St. Rank held Athenex, Inc. Common Stock as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.